Pfizer's $68 billion buyout of Wyeth gets clearance in Australia, still awaiting US clearanceSeptember 30th, 2009 Pfizer, Wyeth deal gets clearance in AustraliaNEW YORK — Drug developer Pfizer says the Australian Competition and Consumer Commission approved the company's $68 billion buyout of rival Wyeth. Pfizer will divest certain animal health assets in Australia, the New York-based company says.
Pfizer's $68 billion buyout of Wyeth gets clearance in China, still awaiting US clearanceSeptember 30th, 2009 Pfizer, Wyeth deal gets clearance in ChinaNEW YORK — Drug developer Pfizer Inc. said Tuesday China's ministry of commerce approved the company's $68 billion buyout of rival Wyeth.
Officials: Pfizer paying record $2.3B settlement for illegal prescription drug promotionsSeptember 2nd, 2009 Officials: Pfizer to pay record $2.3B penaltyWASHINGTON — People familiar with a record settlement to be announced Wednesday say Pfizer Inc., the world's largest drugmaker, will pay a $2.3 billion civil penalty over unlawful prescription drug promotions. The U.S. Justice Department plans a news conference later in the day with FBI, federal prosecutors, and Health and Human Services Department officials to announce the terms of the deal.
Repeat offender Pfizer paying record $2.3B settlement for illegal drug promotionsSeptember 2nd, 2009 Pfizer to pay record $2.3B penalty for drug promosWASHINGTON — Federal prosecutors hit Pfizer Inc. with a record-breaking $2.3 billion in fines Wednesday and called the world's largest drugmaker a repeating corporate cheat for illegal drug promotions that plied doctors with free golf, massages, and resort junkets.
Pfizer paying record $2.3B settlement for illegal promotions of 4 prescription drugsSeptember 2nd, 2009 Pfizer to pay record $2.3B penalty over promotionsWASHINGTON — Federal prosecutors hit Pfizer Inc. with a record-breaking $2.3 billion in fines Wednesday and called the world's largest drug maker a repeating corporate cheat for illegal drug promotions that plied doctors with free golf, massages, and resort junkets.
Drugmaker Pfizer's 2Q profit plunges 19 percent on Wyeth acquisition charges, stronger dollarJuly 22nd, 2009 Drugmaker Pfizer's 2Q profit plunges 19 percentTRENTON, N.J. — Drug giant Pfizer Inc.
Heinz, Morgan Stanley, Pfizer, Starbucks, Intel are among big market movers WednesdayJuly 22nd, 2009 Heinz, Morgan Stanley, Pfizer are big moversNEW YORK — Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and Nasdaq Stock Market:
NYSE:
H.J. Heinz Co., up 36 cents at $37.65
The Pittsburg-based food maker said its finance subsidiary plans to offer $250 million in notes through a private placement.
98 percent of shareholders of drugmaker Wyeth vote to be acquired by industry giant PfizerJuly 20th, 2009 Wyeth shareholders vote to be acquired by PfizerTRENTON, N.J. — Shareholders of drugmaker Wyeth on Monday voted overwhelmingly to be bought by industry giant Pfizer Inc., pushing aside one of the deal's final hurdles.
Pfizer pulls out of plan to move biotech workers to San Francisco facilityJuly 7th, 2009 Pfizer ends plan San Francisco biotech facilityNEW YORK — Pfizer Inc. is pulling a plan to staff a biotechnology research center in San Francisco and will keep its 100 area employees in South San Francisco.
San Francisco DA defends graduating illegal immigrants from a job programJune 24th, 2009 SF DA defends program training illegal immigrantsSAN FRANCISCO — San Francisco's district attorney is defending a city-led job program for first-time drug offenders that has included at least six illegal immigrants. The program came under fire after the Los Angeles Times reported earlier this week that immigrants who didn't have authorization were included.
Drugmaker Wyeth sets July annual meeting for shareholders to vote on acquisition by PfizerJune 18th, 2009 Wyeth sets meeting for shareholders' merger voteMORRISTOWN, N.J. — Wyeth has scheduled a meeting for the drugmaker's shareholders to vote whether to approve its pending acquisition by drug giant Pfizer.
Watson Pharmaceuticals to buy private generic drug maker Arrow Group for $1.75B in cash, stockJune 17th, 2009 Watson Pharma to buy Arrow group for $1.75BNEW YORK — Watson Pharmaceuticals Inc. said Wednesday it will buy smaller generic drug maker Arrow Group for $1.75 billion in cash and stock.
Drugmaker Pfizer's Q1 profit dips 2 percent on much lower sales, costs of Wyeth acquisitionApril 28th, 2009 Pfizer profit dips 2 percent, sales fall much moreNEW YORK — Pfizer Inc. posts a 2 percent drop in first-quarter profit, as cost-cutting by the world's largest drugmaker couldn't offset big drops in sales for several medicines.
Pfizer offers Rs.6.8 bn to raise stake in Indian armApril 13th, 2009 MUMBAI - Global pharmaceutical major Pfizer Monday said it will make an offer to acquire a further 33.77 percent in its Indian subsidiary Pfizer Ltd for Rs.6.8 billion. The acquisition will raise its stake to 75 percent.
US stocks gain despite job cuts, buoyed by Pfizer dealJanuary 26th, 2009 NEW YORK - A volatile session on Wall Street ended higher Monday, the markets buoyed by news of a $68-billion deal between pharmaceutical giant Pfizer Inc and its competitor Wyeth. US companies announced tens of thousands of new job cuts Monday as the world's largest economy continues to battle through a serious recession, prompting another urgent call to action by President Barack Obama.
Loading ...